Proposatutako topikoa bilaketarako iradokizunak
Proposatutako topikoa bilaketarako iradokizunak
- COVID-19
- Research
- SARS-CoV-2 42
- immunology
- COVID-19 (Disease) 38
- Coronavirus infections 24
- Coronavirus Infections 20
- Immunological aspects 20
- COVID-19 Pandemic, 2020- 18
- COVID-19 Vaccines 16
- Vaccination 16
- prevention & control 16
- Pandemics 14
- Betacoronavirus 12
- Development 12
- drug therapy 12
- Treatment 10
- Vaccines 10
- Pneumonia, Viral 8
- drug effects 8
- therapeutic use 8
- Antibodies, Monoclonal 6
- Antiviral agents 6
- Complications 6
- Covid-19 (Disease) 6
- Drug Development 6
- Immunity 6
- Monoclonal antibodies 6
- T-Lymphocytes 6
- Therapeutic use 6
-
1
COVID-19 the anti-viral immune response /
Argitaratua 2022Testu osoa
Series
Baliabide elektronikoa Bideoa -
2
SARS-CoV-2 monoclonal antibody testing in vivo
Argitaratua 2021Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
3
mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals
Argitaratua 2021Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
4
SARS-COV-2 human monoclonal antibody therapy update
Argitaratua 2021Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
5
Emergence of blood clotting disorders resulting from COVID vaccines inoculations
Argitaratua 2021Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
6
The immune system response to the SARS-CoV-2 virus March 2021 update /
Argitaratua 2021Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
7
Comparison of COVID-19 and seasonal HCoV pathologies and transfer to endemic state
Argitaratua 2021Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
8
Complement activation in COVID-19
Argitaratua 2021Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
9
The immune system response to the SARS-CoV-2 virus December 2020 update /
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
10
Imperial College London's saRNA Vaccine - COVAC1
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
11
Potential long-term health effects of a SARS-CoV-2 infection
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
12
The COVID-19 coronavirus outbreak October 2020 update /
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
13
Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
14
Rheumatic diseases and COVID-19
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
15
Risk of re-emergence of COVID-19 after exit from lockdown
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
16
The immune system response to the SARS-CoV-2 virus July 2020 update /
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
17
Human challenge trials for vaccines against COVID-19
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
18
SARS-CoV-2 human monoclonal antibody therapy
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
19
SARS-COV-2 vaccine development where are we now? /
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa -
20
SARS-COV-2 what we need to know and possible future therapies /
Argitaratua 2020Testu osoa
Series
Baliabide elektronikoa Entzunezkoa